University of Michigan secures adult stem cell lines

According to The Detroit News, The University of Michigan has secured three new adult stem cell lines donated from the skin of adults with bipolar disorder, as well as two more lines of genetically normal cells from a tissue back. These will join the three lines of embryotic cells UM already has to study hemophilia, and Marie-Charcot-Tooth disease and a control line of genetically normal cells. These studies, coming from universities, form the basis for dozens of cell therapies that are moving to the clinic. At the Cell Therapy Commercialization Summit, Brock Reeve, Executive Director of the Harvard Stem Cell Institute, will discuss how cell therapy products are moving from the bench to the boardroom.

Share this article with your social network, just click below to share now!

Share |